Brinton Pharmaceuticals Limited

Brinton Pharmaceuticals Limited - pharma in Pune, Maharashtra, India. FY 2026 financials and compliance.
CIN U24232PN2013PLC148971 Incorporated 27 September 2013 ROC Pune HQ Pune, Maharashtra, India
Active Public Limited Company pharma
Data last updated
Revenue · FY 2025
₹215.48 Cr
▲ 15.00% YoY
EBITDA · FY 2025
Locked
In full report
Net profit · FY 2025
Locked
In full report
Authorised capital
₹2 Cr
Registered with MCA
Paid-up capital
₹1.09 Cr
Issued & subscribed
Open charges
₹75.25 Cr
Satisfied ₹81.5 Cr
Company age
13 yrs
Est. 2013
Employees · EPFO
508
Latest available

About Brinton Pharmaceuticals Limited

Data last updated: 21 December 2025

Brinton Pharmaceuticals Limited is a public limited company based in Pune, Maharashtra, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 27 September 2013, the company has been in operation for over 13 years.

Registered with ROC Pune under CIN U24232PN2013PLC148971.

Capital: an authorised share capital of ₹2 Cr and a paid-up capital of ₹1.09 Cr. It is led by directors including Rahul Kundanmal Darda and Ronak Hemprakash Shah.

Last AGM: 30 September 2024. Financial statements filed for year ended 31 March 2024. Office: S. No 55/2 Kharadi Taluka Haveli, Pune, Maharashtra, India – 411014.

As per the financials filed for FY 2025, the company reported a revenue of ₹215.48 Cr, a growth of 15% compared to the previous year.

The company has a workforce of approximately 508 employees as per the latest available data. Its group structure includes 1 subsidiary.

The company is associated with 1 brand - Brinton Pharmaceuticals. As per MCA filings, the company has open charges of ₹75.25 Cr and satisfied charges of ₹81.5 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website brintonhealth.com.

Company Details of Brinton Pharmaceuticals Limited
CIN U24232PN2013PLC148971
Registration Number 148971
Incorporation Date 27 September 2013
ROC Pune
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
  • Registered Address
    S. No 55/2 Kharadi Taluka Haveli, Pune, Maharashtra, India – 411014
  • Industry
    Pharma, Drug Formulation & Development
Company report
Brinton Pharmaceuticals Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Brinton Pharmaceuticals Limited report

Financials, compliance, directors, charges, ownership and filings for Brinton Pharmaceuticals Limited in one report.

10-year financials Directors & ownership Charges & compliance

Associated Brands with Brinton Pharmaceuticals Limited

Brinton Pharmaceuticals Limited operates one associated brand: Brinton Pharmaceuticals. These brands represent Brinton Pharmaceuticals Limited's diversified market presence and brand portfolio.

Brand Description Website
Pharmaceutical formulations for dermatology, gastroenterology, and wellness are manufactured. brintonhealth.com

Competitors & Alternatives of Brinton Pharmaceuticals Limited

Brands and companies operating in the same space as Brinton Pharmaceuticals Limited include LEO Pharma, Formation Bio, Arcutis and 7 more.

Competitor Description Location Founded
LEO Pharma LEO Pharma Developer of drugs for treating dermatology diseases Copenhagen, Denmark, Denmark 1908
Formation Bio Formation Bio AI-powered drug discovery platform for various diseases New York, United States, United States 2016
Arcutis Arcutis Immunotherapeutic solutions for dermatological conditions are developed. Westlake Village, United States, United States 2016
Incyte Incyte Small molecules are developed for cancer and skin disease treatments. Wilmington, United States, United States 1991
Azitra Azitra Microbiome-based therapeutics for skin conditions like eczema are developed. Farmington, United States, United States 2014
Evommune Evommune Developer of therapeutic options for chronic inflammatory disorders Sacramento, United States, United States 2020
Novan Novan Nitric oxide-based therapeutics for dermatology disorders are developed. Morrisville, United States, United States 2006
DermBiont DermBiont Microbial therapeutics for skin diseases are developed. Melrose, United States, United States 2015
Verrica Pharmaceuticals Verrica Pharmaceuticals Therapeutic solutions for skin diseases like molluscum contagiosum are developed. West Chester, United States, United States 2013
Edesa Biotech Edesa Biotech Topical therapeutics for dermatological and gastrointestinal diseases are developed. Toronto, Canada, Canada 2015

Business Activity of Brinton Pharmaceuticals Limited

Brinton Pharmaceuticals Limited is engaged in the principal business activity of trade, with detailed activities including wholesale trading.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
G Trade G1 Wholesale Trading Locked
Premium access

Business activity turnover details for Brinton Pharmaceuticals Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Brinton Pharmaceuticals Limited

Brinton Pharmaceuticals Limited is audited by M S K A & Associates for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
M S K A & Associates Locked Locked Locked
Premium access

Complete auditor history for Brinton Pharmaceuticals Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Brinton Pharmaceuticals Limited

Brinton Pharmaceuticals Limited is currently managed by 7 directors, with 8 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Rahul Kundanmal Darda Managing Director 27 Sep 2013 12 Years 10 Months Current
Ronak Hemprakash Shah Director 28 Mar 2024 2 Years 4 Months Current
Chaitali Rahul Darda Director 27 Sep 2013 12 Years 10 Months Current
Shivani Bhasin Nominee Director 13 Jun 2019 7 Years 2 Months Current
Visalakshi Chandramouli Nominee Director 30 Mar 2017 9 Years 4 Months Current
Sudeep Chhallani Director 28 Mar 2024 2 Years 4 Months Current
Showing 6 of 7 current directors. View all directors

Financials of Brinton Pharmaceuticals Limited FY 2024 filings available

Brinton Pharmaceuticals Limited reported revenue of ₹215.48 Cr (up 15.00% YoY) for FY 2025.

Revenue · FY 2025
₹215.48 Cr ▲ 15.00%
Premium access

Ten-year financial statements for Brinton Pharmaceuticals Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Brinton Pharmaceuticals Limited

Premium access

Shareholding and ownership data for Brinton Pharmaceuticals Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Group Structure of Brinton Pharmaceuticals Limited

Brinton Pharmaceuticals Limited has 1 subsidiary company. This group structure data is as of FY 2023. The corporate group structure reflects Brinton Pharmaceuticals Limited's business expansion strategy and organizational complexity.

1
Subsidiary companies
Key Subsidiaries
Company Name CIN Shares Held
Brinton Healthcare Limited U24297PN2019PLC187750 Locked

Showing major subsidiaries. Total: 1.

Charges & Borrowings of Brinton Pharmaceuticals Limited

Open charges
₹75.25 Cr
Satisfied charges
₹81.5 Cr
Breakdown by lending institutions
Others₹75.25 Cr
Latest charge details
DateLenderAmountStatus
27 Mar 2025 Others ₹75 Cr Open
04 Aug 2020 Others ₹25 Lakh Open
04 Sep 2024 Others ₹4 Cr Satisfied
27 Jun 2023 Others ₹7.5 Cr Satisfied
09 Jun 2023 Others ₹3 Cr Satisfied

Total charge records: 11 View all charges

Employees and EPFO Compliance at Brinton Pharmaceuticals Limited

Brinton Pharmaceuticals Limited has a workforce of 508 employees as of Apr 02, 2024.

Employee count
508
Active EPFO establishments
1
Employee growth
13.65%
Premium access

Employee and EPFO history for Brinton Pharmaceuticals Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Brinton Pharmaceuticals Limited

Premium access

GST registrations and filing compliance for Brinton Pharmaceuticals Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Brinton Pharmaceuticals Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Brinton Pharmaceuticals Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Brinton Pharmaceuticals Limited

Premium access

MSME payment history for Brinton Pharmaceuticals Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Brinton Pharmaceuticals Limited

Premium access

Corporate group structure for Brinton Pharmaceuticals Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Brinton Pharmaceuticals Limited

Premium access

MCA filings and documents for Brinton Pharmaceuticals Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Brinton Pharmaceuticals Limited

Charges
17 Apr 2025
A charge registered on 30 Aug 2021 via Charge ID 100514652 with Others was fully satisfied on 17 Apr 2025.
Charges
16 Apr 2025
A charge registered on 09 Jun 2023 via Charge ID 100730089 with Others was fully satisfied on 16 Apr 2025.
Charges
15 Apr 2025
A charge registered on 31 Jan 2023 via Charge ID 100673056 with Others was fully satisfied on 15 Apr 2025.
Charges
05 Apr 2025
A charge registered on 04 Sep 2024 via Charge ID 100974582 with Others was fully satisfied on 05 Apr 2025.
Charges
01 Apr 2025
A charge registered on 27 Jun 2023 via Charge ID 100750207 with Others was fully satisfied on 01 Apr 2025.
Charges
27 Mar 2025
A charge with Others amounted to Rs. 75.00 Cr with Charge ID 101090172 was registered on 27 Mar 2025.

Frequently Asked Questions about Brinton Pharmaceuticals Limited

Brinton Pharmaceuticals Limited is an active public limited company in the pharma sector based in Pune, Maharashtra, India. It was incorporated on 27 September 2013 (13+ years old) and is registered under CIN U24232PN2013PLC148971. The company has 508 employees.

Brinton Pharmaceuticals Limited reported revenue of ₹215.48 Cr for FY 2025 (up 15.00% YoY).

The current directors of Brinton Pharmaceuticals Limited are:

The primary industry of Brinton Pharmaceuticals Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Brinton Pharmaceuticals Limited can be reached at the registered office: S. No 552 Kharadi Taluka Haveli, Pune, Maharashtra, India – 411014, or through the website brintonhealth.com.

The authorised capital is ₹2 Cr, and the paid-up capital is ₹1.09 Cr.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available